{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T04:55:02Z","timestamp":1782881702643,"version":"3.54.5"},"reference-count":58,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2020,4,7]]},"DOI":"10.3233\/jad-191199","type":"journal-article","created":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T11:17:42Z","timestamp":1582888662000},"page":"999-1009","source":"Crossref","is-referenced-by-count":8,"title":["Neuropathological Correlates of Cumulative Benzodiazepine and Anticholinergic Drug Use"],"prefix":"10.1177","volume":"74","author":[{"given":"Kathryn","family":"Richardson","sequence":"first","affiliation":[{"name":"School of Health Sciences, University of East Anglia, Norwich, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B.","family":"Wharton","sequence":"additional","affiliation":[{"name":"Sheffield Institute for Translational Neuroscience, University of Sheffield, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlota M.","family":"Grossi","sequence":"additional","affiliation":[{"name":"School of Health Sciences, University of East Anglia, Norwich, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona E.","family":"Matthews","sequence":"additional","affiliation":[{"name":"Institute of Health and Society\/Institute for Ageing, Newcastle University, Newcastle, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Fox","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia, Norwich, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Maidment","sequence":"additional","affiliation":[{"name":"School of Life and Health Sciences, Aston University, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon K.","family":"Loke","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia, Norwich, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Steel","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia, Norwich, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antony","family":"Arthur","sequence":"additional","affiliation":[{"name":"School of Health Sciences, University of East Anglia, Norwich, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phyo Kyaw","family":"Myint","sequence":"additional","affiliation":[{"name":"Institute of Applied Health Sciences, University of Aberdeen, Aberdeen, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malaz","family":"Boustani","sequence":"additional","affiliation":[{"name":"School of Medicine, Indiana University, Indianapolis, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noll","family":"Campbell","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, Purdue University, West Lafayette, IN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Robinson","sequence":"additional","affiliation":[{"name":"Institute of Health and Society\/Institute for Ageing, Newcastle University, Newcastle, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Brayne","sequence":"additional","affiliation":[{"name":"Cambridge Institute of Public Health, University of Cambridge, Cambridge, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George M.","family":"Savva","sequence":"additional","affiliation":[{"name":"School of Health Sciences, University of East Anglia, Norwich, UK"},{"name":"Quadram Institute Bioscience, Norwich Research Park, Norwich, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-191199_ref1","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jnnp.66.2.137","article-title":"The cholinergic hypothesis of Alzheimer\u2019s disease: A review of progress","volume":"66","author":"Francis","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-191199_ref2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1056\/NEJM198507043130102","article-title":"Neurochemical studies of early-onset Alzheimer\u2019s disease. Possible influence on treatment","volume":"313","author":"Francis","year":"1985","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-191199_ref3","doi-asserted-by":"crossref","first-page":"k1315","DOI":"10.1136\/bmj.k1315","article-title":"Anticholinergic drugs and risk of dementia: Case-control study","volume":"361","author":"Richardson","year":"2018","journal-title":"BMJ"},{"key":"10.3233\/JAD-191199_ref4","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/jamainternmed.2014.7663","article-title":"Cumulative use of strong anticholinergics and incident dementia: A prospective cohort study","volume":"175","author":"Gray","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.3233\/JAD-191199_ref5","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","article-title":"Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996-2013","volume":"106","author":"Bachhuber","year":"2016","journal-title":"Am J Public Health"},{"key":"10.3233\/JAD-191199_ref6","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/s00228-012-1223-8","article-title":"Inappropriate prescribing for the elderly\u2013a modern epidemic?","volume":"68","author":"Nyborg","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.3233\/JAD-191199_ref7","doi-asserted-by":"crossref","first-page":"g5205","DOI":"10.1136\/bmj.g5205","article-title":"Benzodiazepine use and risk of Alzheimer\u2019s disease: Case-control study","volume":"349","author":"Billioti de Gage","year":"2014","journal-title":"BMJ"},{"key":"10.3233\/JAD-191199_ref8","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/aje\/kwz073","article-title":"History of benzodiazepine prescriptions and risk of dementia: Possible bias due to prevalent users and covariate measurement timing in a nested case-control study","volume":"188","author":"Richardson","year":"2019","journal-title":"Am J Epidemiol"},{"key":"10.3233\/JAD-191199_ref9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/1060028019882037","article-title":"Is benzodiazepine use associated with the risk of dementia and cognitive impairment\u2013not dementia in older persons? The Canadian Study of Health and Aging","volume":"54","author":"Nafti","year":"2020","journal-title":"Ann Pharmacother"},{"key":"10.3233\/JAD-191199_ref10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/ana.10639","article-title":"Increased Alzheimer pathology in Parkinson\u2019s disease related to antimuscarinic drugs","volume":"54","author":"Perry","year":"2003","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-191199_ref11","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1046\/j.1471-4159.1998.71052094.x","article-title":"Mitogen-activated protein kinase-dependent and protein kinase C-dependent pathways link the m1 muscarinic receptor to beta-amyloid precursor protein secretion","volume":"71","author":"Haring","year":"1998","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-191199_ref12","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.neuron.2006.01.020","article-title":"M1 receptors play a central role in modulating AD-like pathology in transgenic mice","volume":"49","author":"Caccamo","year":"2006","journal-title":"Neuron"},{"key":"10.3233\/JAD-191199_ref13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.nbd.2011.08.017","article-title":"Anticholinergics boost the pathological process of neurodegeneration with increased inflammation in a tauopathy mouse model","volume":"45","author":"Yoshiyama","year":"2012","journal-title":"Neurobiol Dis"},{"key":"10.3233\/JAD-191199_ref14","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3233\/JAD-171174","article-title":"Exposure to strong anticholinergic medications and dementia-related neuropathology in a community-based autopsy cohort","volume":"65","author":"Gray","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-191199_ref15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neurobiolaging.2019.08.008","article-title":"Benzodiazepine use and brain amyloid load in nondemented older individuals: A florbetapir PET study in the Multidomain Alzheimer Preventive Trial (MAPT) cohort","volume":"84","author":"Desmidt","year":"2019","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-191199_ref16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1440-1789.2008.00978.x","article-title":"An immunohistochemical study of GABA A receptor gamma subunits in Alzheimer\u2019s disease hippocampus: Relationship to neurofibrillary tangle progression","volume":"29","author":"Iwakiri","year":"2009","journal-title":"Neuropathology"},{"key":"10.3233\/JAD-191199_ref17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40263-015-0305-4","article-title":"The benzodiazepine\u2013dementia disorders link: Current state of knowledge","volume":"30","author":"Pariente","year":"2016","journal-title":"CNS Drugs"},{"key":"10.3233\/JAD-191199_ref18","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0304-3940(93)90510-R","article-title":"GYKI 52466 protects against non-NMDA receptor-mediated excitotoxicity in primary rat hippocampal cultures","volume":"152","author":"May","year":"1993","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-191199_ref19","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.2174\/156802611795371314","article-title":"GABAA receptor subtype-selective modulators. II. \u03b15-selective inverse agonists for cognition enhancement","volume":"11","author":"Atack","year":"2011","journal-title":"Curr Top Med Chem"},{"key":"10.3233\/JAD-191199_ref20","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1111\/j.1532-5415.2011.03491.x","article-title":"Anticholinergic medication use and cognitive impairment in the older population: The Medical Research Council Cognitive Function and Ageing Study","volume":"59","author":"Fox","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-191199_ref21","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40263-018-0535-3","article-title":"A systematic review and meta-analysis of the risk of dementia associated with benzodiazepine use, after controlling for protopathic bias","volume":"32","author":"Penninkilampi","year":"2018","journal-title":"CNS Drugs"},{"key":"10.3233\/JAD-191199_ref22","doi-asserted-by":"crossref","unstructured":"(1998) Cognitive function and dementia in six areas of England and Wales: The distribution of MMSE and prevalence of GMS organicity level in the MRC CFA Study. The Medical Research Council Cognitive Function and Ageing Study (MRC CFAS). Psychol Med 28, 319\u2013335.","DOI":"10.1017\/S0033291797006272"},{"key":"10.3233\/JAD-191199_ref23","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1093\/ije\/dyl199","article-title":"Cohort profile: The Medical Research Council Cognitive Function and Ageing Study (CFAS)","volume":"35","author":"Brayne","year":"2006","journal-title":"Int J Epidemiol"},{"key":"10.3233\/JAD-191199_ref24","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d. A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-191199_ref25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1017\/S0033291700057779","article-title":"A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT","volume":"16","author":"Copeland","year":"1986","journal-title":"Psychol Med"},{"key":"10.3233\/JAD-191199_ref26","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1192\/bjp.149.6.698","article-title":"CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia","volume":"149","author":"Roth","year":"1986","journal-title":"Br J Psychiatry"},{"key":"10.3233\/JAD-191199_ref27","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(00)03589-3","article-title":"Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS)","volume":"357","author":"Neuropathology Group. Medical Research Council Cognitive Function and Aging Study","year":"2001","journal-title":"Lancet"},{"key":"10.3233\/JAD-191199_ref28","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1007\/BF02189529","article-title":"The epidemiology of dementia: GMS-AGECAT studies of prevalence and incidence, including studies in progress","volume":"240","author":"Copeland","year":"1991","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"10.3233\/JAD-191199_ref29","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1056\/NEJMoa0806142","article-title":"Age, neuropathology, and dementia","volume":"360","author":"Savva","year":"2009","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-191199_ref30","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1212\/WNL.41.4.479","article-title":"The Consortium to Establish a Registry for Alzheimer\u2019s Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer\u2019s disease","volume":"41","author":"Mirra","year":"1991","journal-title":"Neurology"},{"key":"10.3233\/JAD-191199_ref31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-011-0910-3","article-title":"National Institute on Aging-Alzheimer\u2019s Association guidelines for the neuropathologic assessment of Alzheimer\u2019s disease: A practical approach","volume":"123","author":"Montine","year":"2012","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.3233\/JAD-191199_ref32","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.3233\/JAD-191199_ref33","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A beta-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"key":"10.3233\/JAD-191199_ref34","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s40478-019-0858-4","article-title":"Epidemiological pathology of A\u03b2 deposition in the ageing brain in CFAS: Addition of multiple A\u03b2-derived measures does not improve dementia assessment using logistic regression and machine learning approaches","volume":"7","author":"Wharton","year":"2019","journal-title":"Acta Neuropathol Commun"},{"key":"10.3233\/JAD-191199_ref35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1111\/nan.12363","article-title":"Microinfarcts in an older population-representative brain donor cohort (MRC CFAS): Prevalence, relation to dementia and mobility, and implications for the evaluation of cerebral small vessel disease","volume":"43","author":"Ince","year":"2017","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JAD-191199_ref36","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1365-2990.2004.00550.x","article-title":"Comparison of the pathology of cerebral white matter with post-mortem magnetic resonance imaging (MRI) in the elderly brain","volume":"30","author":"Fernando","year":"2004","journal-title":"Neuropathol Appl Neurobiol"},{"key":"10.3233\/JAD-191199_ref37","doi-asserted-by":"crossref","first-page":"e1000180","DOI":"10.1371\/journal.pmed.1000180","article-title":"Epidemiological pathology of dementia: Attributable-risks at death in the Medical Research Council Cognitive Function and Ageing Study","volume":"6","author":"Matthews","year":"2009","journal-title":"PLoS Med"},{"key":"10.3233\/JAD-191199_ref38","first-page":"S1","article-title":"The 2012 update to the Anticholinergic Cognitive Burden Scale","volume":"61","author":"Campbell","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-191199_ref39","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: A practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Ser B Methodol"},{"key":"10.3233\/JAD-191199_ref40","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1001\/jamaneurol.2016.0580","article-title":"Association between anticholinergic medication use and cognition, brain metabolism, and brain atrophy in cognitively normal older adults","volume":"73","author":"Risacher","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.3233\/JAD-191199_ref41","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S1474-4422(16)30030-8","article-title":"Cortical atrophy in patients with cerebral amyloid angiopathy: A case-control study","volume":"15","author":"Fotiadis","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-191199_ref42","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.trci.2017.06.004","article-title":"Midlife anticholinergic drug use, risk of Alzheimer\u2019s disease, and brain atrophy in community-dwelling older adults","volume":"3","author":"Chuang","year":"2017","journal-title":"Alzheimers Dement (N Y)"},{"key":"10.3233\/JAD-191199_ref43","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.neuron.2014.08.030","article-title":"Isolating pathogenic mechanisms embedded within the hippocampal circuit through regional vulnerability","volume":"84","author":"Small","year":"2014","journal-title":"Neuron"},{"key":"10.3233\/JAD-191199_ref44","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s11682-016-9631-5","article-title":"Neuropsychiatric symptoms of cholinergic deficiency occur with degradation of the projections from the nucleus basalis of Meynert","volume":"11","author":"Dalen","year":"2017","journal-title":"Brain Imaging Behav"},{"key":"10.3233\/JAD-191199_ref45","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00401-015-1392-5","article-title":"Nucleus basalis of Meynert revisited: Anatomy, history and differential involvement in Alzheimer\u2019s and Parkinson\u2019s disease","volume":"129","author":"Liu","year":"2015","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.3233\/JAD-191199_ref46","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.biopsych.2011.06.019","article-title":"Atrophy of the cholinergic basal forebrain over the adult age range and in early stages of Alzheimer\u2019s disease","volume":"71","author":"Grothe","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.3233\/JAD-191199_ref47","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2019.3606"},{"key":"10.3233\/JAD-191199_ref48","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s00204-015-1540-7","article-title":"Cadmium-induced cell death of basal forebrain cholinergic neurons mediated by muscarinic M1 receptor blockade, increase in GSK-3\u03b2 enzyme, \u03b2-amyloid and tau protein levels","volume":"90","author":"Pino","year":"2016","journal-title":"Arch Toxicol"},{"key":"10.3233\/JAD-191199_ref49","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/00001756-200004070-00007","article-title":"Differential vulnerability of primary cultured cholinergic neurons to nitric oxide excess","volume":"11","author":"Fass","year":"2000","journal-title":"Neuroreport"},{"key":"10.3233\/JAD-191199_ref50","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1046\/j.1471-4159.1995.65052157.x","article-title":"Altered cholinergic metabolism in rat CNS following aluminum exposure: Implications on learning performance","volume":"65","author":"Julka","year":"1995","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-191199_ref51","first-page":"404","article-title":"Revisiting the cholinergic hypothesis of behavioral and psychological symptoms in dementia of the Alzheimer\u2019s type","volume":"10","author":"Pinto","year":"2011","journal-title":"Ageing Res Rev"},{"key":"10.3233\/JAD-191199_ref52","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000066508","article-title":"The cholinergic deficiency syndrome and its therapeutic implications","volume":"49","author":"Lemstra","year":"2003","journal-title":"Gerontology"},{"key":"10.3233\/JAD-191199_ref53","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/332448a0","article-title":"Cholinergic-rich brain transplants reverse alcohol-induced memory deficits","volume":"332","author":"Arendt","year":"1988","journal-title":"Nature"},{"key":"10.3233\/JAD-191199_ref54","first-page":"1841","article-title":"Parallel atrophy of cortex and basal forebrain cholinergic system in mild cognitive impairment","volume":"27","author":"Kilimann","year":"2017","journal-title":"Cereb Cortex"},{"key":"10.3233\/JAD-191199_ref55","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000381484","article-title":"Does anticholinergic activity affect neuropathology? Implication of neuroinflammation in Alzheimer\u2019s disease","volume":"15","author":"Yoshiyama","year":"2015","journal-title":"Neurodegener Dis"},{"key":"10.3233\/JAD-191199_ref56","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/(SICI)1099-1166(200001)15:1<14::AID-GPS70>3.0.CO;2-8","article-title":"Dementia in developing countries. A consensus statement from the 10\/66 Dementia Research Group","volume":"15","author":"Prince","year":"2000","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-191199_ref57","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1212\/01.wnl.0000191298.68045.50","article-title":"Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease","volume":"66","author":"Prohovnik","year":"2006","journal-title":"Neurology"},{"key":"10.3233\/JAD-191199_ref58","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2165\/00002512-200320030-00006","article-title":"Interventions to improve medication compliance in older patients living in the community: A systematic review of the literature","volume":"20","author":"van Eijken","year":"2003","journal-title":"Drugs Aging"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-191199","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:48Z","timestamp":1777370868000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-191199"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,7]]},"references-count":58,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-191199","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,7]]}}}